13. Goodwill and Other Intangible Assets
|
|
|
|
|
|
|
|
|
||||||||
|
Acquired goodwill |
Patents and technologies |
Marketing and distribution rights |
Production rights |
Software |
Other rights |
Advance payments |
Total |
||||||||
|
€ million |
€ million |
€ million |
€ million |
€ million |
€ million |
€ million |
€ million |
||||||||
Cost of acquisition or generation, December 31, 2017 |
253 |
30 |
105 |
96 |
147 |
176 |
9 |
816 |
||||||||
Acquisitions |
– |
– |
– |
– |
– |
– |
– |
– |
||||||||
Capital expenditures |
– |
– |
– |
– |
3 |
1 |
12 |
16 |
||||||||
Retirements |
– |
– |
– |
– |
(1) |
(1) |
– |
(2) |
||||||||
Transfers |
– |
– |
– |
– |
6 |
– |
(6) |
– |
||||||||
Transfers (IFRS 5) |
(1) |
(2) |
– |
– |
– |
(1) |
– |
(4) |
||||||||
Exchange differences |
4 |
– |
– |
1 |
2 |
1 |
– |
8 |
||||||||
Cost of acquisition or generation, December 31, 2018 |
256 |
28 |
105 |
97 |
157 |
176 |
15 |
834 |
||||||||
|
|
|
|
|
|
|
|
|
||||||||
Accumulated amortization, impairment losses and impairment loss reversals, December 31, 2018 |
– |
13 |
85 |
92 |
147 |
164 |
– |
501 |
||||||||
Carrying amounts, December 31, 2018 |
256 |
15 |
20 |
5 |
10 |
12 |
15 |
333 |
||||||||
Amortization and impairment losses in 2018 |
– |
1 |
7 |
2 |
9 |
2 |
– |
21 |
||||||||
Amortization |
– |
1 |
7 |
2 |
9 |
2 |
– |
21 |
||||||||
Impairment losses |
– |
– |
– |
– |
– |
– |
– |
– |
No impairment losses were recognized or reversed either in the reporting period or in the reference period.
The impairment testing procedure for goodwill and other intangible assets is explained under “Procedure used in global impairment testing and its impact” in note 3.
|
|
|
|
|
|
|
|
|
||||||||
|
Acquired goodwill |
Patents and technologies |
Marketing and distribution rights |
Production rights |
Software |
Other rights |
Advance payments |
Total |
||||||||
|
€ million |
€ million |
€ million |
€ million |
€ million |
€ million |
€ million |
€ million |
||||||||
Cost of acquisition or generation, December 31, 2016 |
264 |
38 |
114 |
98 |
144 |
321 |
7 |
986 |
||||||||
Acquisitions |
2 |
– |
– |
– |
– |
– |
– |
2 |
||||||||
Capital expenditures |
– |
– |
– |
– |
2 |
– |
9 |
11 |
||||||||
Retirements |
– |
– |
(1) |
– |
(3) |
(140) |
– |
(144) |
||||||||
Transfers |
– |
– |
1 |
– |
6 |
– |
(7) |
– |
||||||||
Transfers (IFRS 5) |
– |
(6) |
(8) |
– |
– |
– |
– |
(14) |
||||||||
Exchange differences |
(13) |
(2) |
(1) |
(2) |
(2) |
(5) |
– |
(25) |
||||||||
Cost of acquisition or generation, December 31, 2017 |
253 |
30 |
105 |
96 |
147 |
176 |
9 |
816 |
||||||||
|
|
|
|
|
|
|
|
|
||||||||
Accumulated amortization, impairment losses and impairment loss reversals, December 31, 2017 |
– |
13 |
78 |
90 |
138 |
163 |
– |
482 |
||||||||
Carrying amounts, December 31, 2017 |
253 |
17 |
27 |
6 |
9 |
13 |
9 |
334 |
||||||||
Amortization and impairment losses in 2017 |
– |
1 |
7 |
2 |
10 |
5 |
– |
25 |
||||||||
Amortization |
– |
1 |
7 |
2 |
10 |
5 |
– |
25 |
||||||||
Impairment losses |
– |
– |
– |
– |
– |
– |
– |
– |
Goodwill that is of material significance for the Covestro Group was allocated to the following cash-generating units at the end of the reporting period:
|
|
|
|
|||
|
Cash-generating unit |
Dec. 31, 2017 |
Dec. 31, 2018 |
|||
Reporting segment |
|
€ million |
€ million |
|||
PUR |
MDI |
59 |
61 |
|||
PUR |
Polyether polyols |
22 |
23 |
|||
PCS |
PCS |
121 |
121 |
|||
CAS |
BMI |
37 |
38 |
|||
CAS |
Resins |
10 |
10 |
The transfer of the specialty elastomers business from the Polyurethanes segment to the Coatings, Adhesives, Specialties segment as of January 1, 2018, led to the transfer of goodwill amounting to €6 million between the MDI and BMI cash-generating units. The prior-year figures were adjusted in the MDI (€-6 million) and BMI (€+6 million) cash-generating units.